Why Herbalife, Steel Partners Holdings, and Achillion Pharmaceuticals Jumped Today

Monday was largely a down day for the stock market, as the once-flying biotech sector again weighed on the broader indexes. But these stocks jumped sharply. Find out why.

Mar 24, 2014 at 8:00PM

Monday was an up-and-down day on Wall Street, as major stock market benchmarks moved on both sides of unchanged before settling down on the day. Biotech stocks weighed especially hard on the Nasdaq, but that didn't keep some stocks from scoring impressive gains. Herbalife (NYSE:HLF), Steel Partners Holdings (NYSE:SPLP), and Achillion Pharmaceuticals (NASDAQ:ACHN) were among the biggest winners today.

Herbalife gained 7% as activist investor Carl Icahn gained control of three more director seats on the multi-level marketing company's board. With an investigation into the company's practices having recently begun, Herbalife stock is well off its highs as fearful investors worry that the company could have its business model threatened. Yet Icahn remains optimistic that Herbalife represents a solid value and has plenty of growth potential ahead. Moreover, Herbalife also likely gained from news that peer Nu Skin Enterprises (NYSE:NUS) avoided the brunt of potential damage from Chinese regulators, paying fines of less than $1 million in connection with its practices in the emerging-market nation.

Steel Partners Holdings rose 8% after the limited partnership announced that it would buy up to $49 million worth of its partnership units in a Dutch auction. The holding company is an interesting conglomeration of businesses in different industries, ranging from a combination well-completion and sports-services company to hot-dog giant Nathan's Famous, and it has historically traded at a value well below the sum total of its holdings. With the Dutch-auction tender offer, Steel Partners is aiming to boost its unit price while also giving it a chance to buy back partnership units at an attractive valuation.

Achillion Pharmaceuticals rose 7% after the biotech company got an upgrade from Maxim Group. The maker of the once-promising hepatitis-C treatment sovaprevir got crushed last fall, when the FDA chose not to lift a clinical hold on the drug that the agency had originally imposed earlier last year. Yet after that big drop, some believe that unlike other high-flying biotech stocks, Achillion represents a reasonable value at current prices. There's still plenty of risk given Achillion's historical inability to get promising treatments all the way through clinical trials, but with the stock down, analysts see it as a worthwhile gamble.

2 biotechs changing the way we treat cancer
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Dan Caplinger has no position in any stocks mentioned. The Motley Fool has options on Herbalife. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers